ACS CAN Joins More Than 30 Patient and Provider Groups Applauding Supreme Court Ruling, Urging Courts to Preserve FDA’s Authority
ACS CAN joined 32 patient and provider groups 33 organizations applauding the Supreme Court’s decision to pause new restrictions that would have limited access to the FDA-approved drug mifepristone while litigation about the drug works its way through the courts.